Drug Shortage Report for OXYTOCIN INJECTION, USP

Last updated on 2019-11-28 History
Report ID 93921
Drug Identification Number 02139561
Brand name OXYTOCIN INJECTION
Common or Proper name Oxytocin Injection
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) OXYTOCIN
Strength(s) 10UNIT
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS
Packaging size 1mL
ATC code H01BB
ATC description POSTERIOR PITUITARY LOBE HORMONES
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2019-09-30
Estimated end date 2019-11-08
Actual end date 2019-11-08
Shortage status Resolved
Updated date 2019-11-28
Company comments Stock Available
Health Canada comments
Tier 3 Status No
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2019-11-28 French Compare
v10 2019-11-28 English Compare
v9 2019-10-28 French Compare
v8 2019-10-28 English Compare
v7 2019-10-04 French Compare
v6 2019-10-04 English Compare
v5 2019-10-04 French Compare
v4 2019-10-04 English Compare
v3 2019-09-14 English Compare
v2 2019-09-13 French Compare
v1 2019-09-13 English Compare

Showing 1 to 11 of 11